CK Hutchison Holdings

Pharus Diagnostics Signs Worldwide Exclusive License Agreement with City of Hope for Novel Biomarkers to Be Used in Liquid Biopsy Screening for Early Pancreatic Cancer Diagnosis

Retrieved on: 
Thursday, February 15, 2024
Diabetes, Obesity, Cancer, CK Life Sciences, Goel, Risk, CK Hutchison Holdings, MicroRNA, Biomarker, History, Therapy, PDAC, Tobacco, Patient, Pancreas, Disease, Diagnosis, Machine learning, AGAF, Molecular diagnostics, Pancreatic cancer, Mortality, Abdominal cavity, Research, Insurance, Medical imaging

LOS ANGELES, Feb. 15, 2024 /PRNewswire/ -- Pharus Diagnostics ("PharusDx") today announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be used in early screening of individuals at risk for pancreatic ductal adenocarcinoma (PDAC).

Key Points: 
  • LOS ANGELES, Feb. 15, 2024 /PRNewswire/ -- Pharus Diagnostics ("PharusDx") today announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be used in early screening of individuals at risk for pancreatic ductal adenocarcinoma (PDAC).
  • This license agreement marks a pivotal step with PharusDx to develop and commercialize a version of its OncoSweep™ liquid biopsy screening for the early detection of PDAC.
  • The poor survival rate is mainly due to late-stage diagnosis, attributed to the pancreas' deep location within the abdominal cavity.
  • The current challenge of asymptomatic early diagnosis of PDAC is anticipated to be addressed by PharusDx's liquid biopsy miRNA test: OncoSweep™.

DRAGONFLY BIOSCIENCES UK INCREASES BRAND VALUE GLOBALLY

Retrieved on: 
Tuesday, July 18, 2023
Heart, Note, Boots (company), Ireland, Education, Face, Dragonfly, ASX, Research, Pharmacy, Carbon, USD, Government, Vitamin D, CK Hutchison Holdings, Republic, Boot, Digital technology, Nature, Soil, Investment, A.S. Watson Group, CBD, Health, CO2, DRF, COA, Dietary supplement, Superdrug

LONDON, July 18, 2023 /PRNewswire/ -- British Company, Dragonfly Biosciences UK, the brains behind Dragonfly CBD, Europe's largest and leading, award-winning seed to shelf range of CBD oils and skincare products, is expanding its retail footprint into Superdrug. Superdrug is part of the world's largest international health, wellness and beauty retailer - the A.S. Watson Group. The Group operates more than 16,000 stores in 28 markets, serving over 5.5 billion customers per annum.

Key Points: 
  • Regan Saveall, CEO of Dragonfly Biosciences UK says: "We keep innovation and quality at the heart of the Dragonfly CBD brand and we believe that this strategy is what is driving our success.
  • Superdrug has established itself as a leading, innovative multichannel health and beauty destination in the UK and Dragonfly Biosciences UK will be committing to significant investments in initiatives to provide broader access to customers.
  • Regan Saveall added "Although this expansion primarily affects the UK, A.S. Watson is part of the Hong Kong conglomerate CK Hutchison Holdings, making it an exciting development for Dragonfly Biosciences UK as we expand globally, particularly in the Asia-Pacific region.
  • Dragonfly Biosciences UK owns certified organic land and licensed dedicated CBD extraction facilities – used alongside stringent testing in third-party laboratories that are globally recognised.

DRAGONFLY BIOSCIENCES UK INCREASES BRAND VALUE GLOBALLY

Retrieved on: 
Tuesday, July 18, 2023
Heart, Note, Boots (company), Ireland, Education, Face, Dragonfly, ASX, Research, Pharmacy, Carbon, USD, Government, Vitamin D, CK Hutchison Holdings, Republic, Boot, Digital technology, Nature, Soil, Investment, A.S. Watson Group, CBD, Health, CO2, DRF, COA, Dietary supplement, Superdrug

LONDON, July 18, 2023 /PRNewswire/ -- British Company, Dragonfly Biosciences UK, the brains behind Dragonfly CBD, Europe's largest and leading, award-winning seed to shelf range of CBD oils and skincare products, is expanding its retail footprint into Superdrug. Superdrug is part of the world's largest international health, wellness and beauty retailer - the A.S. Watson Group. The Group operates more than 16,000 stores in 28 markets, serving over 5.5 billion customers per annum.

Key Points: 
  • Regan Saveall, CEO of Dragonfly Biosciences UK says: "We keep innovation and quality at the heart of the Dragonfly CBD brand and we believe that this strategy is what is driving our success.
  • Superdrug has established itself as a leading, innovative multichannel health and beauty destination in the UK and Dragonfly Biosciences UK will be committing to significant investments in initiatives to provide broader access to customers.
  • Regan Saveall added "Although this expansion primarily affects the UK, A.S. Watson is part of the Hong Kong conglomerate CK Hutchison Holdings, making it an exciting development for Dragonfly Biosciences UK as we expand globally, particularly in the Asia-Pacific region.
  • Dragonfly Biosciences UK owns certified organic land and licensed dedicated CBD extraction facilities – used alongside stringent testing in third-party laboratories that are globally recognised.

EQS-News: CK Hutchison forms mobile network company in Italy with EQT Infrastructure

Retrieved on: 
Friday, May 12, 2023
B2B, SAR, Telecommunications, Internet of things, EQT Partners, CAPEX, EQT, CK Hutchison Holdings, WINDTRE, OPEX, News, Security (finance), Bank

HONG KONG SAR - Media OutReach - 12 May 2023 - CK Hutchison Group Telecom (“CKHGT”), a wholly owned subsidiary of CK Hutchison Holdings Limited, and EQT Infrastructure, part of the global private equity firm EQT, have agreed to form a new company (“Company”) that will provide wholesale mobile and wholesale fixed communications services in Italy.

Key Points: 
  • HONG KONG SAR - Media OutReach - 12 May 2023 - CK Hutchison Group Telecom (“CKHGT”), a wholly owned subsidiary of CK Hutchison Holdings Limited, and EQT Infrastructure, part of the global private equity firm EQT, have agreed to form a new company (“Company”) that will provide wholesale mobile and wholesale fixed communications services in Italy.
  • CKHGT’s Italian mobile business, WINDTRE, will transfer its active network equipment and wholesale mobile and wholesale fixed communications services business in Italy to the new Company, which will be 60% owned by EQT Infrastructure while CKHGT will hold 40%.
  • It will consist of four members nominated by EQT Infrastructure and CKHGT (two each respectively) as well as several independents.
  • Furthermore, customers of the new Company will have the assurance of collaborating with a mobile network operator with its own separate management independent of WINDTRE.

EQT Infrastructure to acquire a majority stake in Italy's largest mobile network from Wind Tre

Retrieved on: 
Friday, May 12, 2023
Partnership, Telecommunications, Wind, EQT Partners, Person, Internet, EUR, EQT, The Company, Investment, Radio, CK Hutchison Holdings, Mobile phone, Renewable energy, Financial services, Internet of things

EQT Infrastructure to acquire a 60 percent stake in newly created company which will own and operate the Italian telecom provider Wind Tre's mobile and fixed network.

Key Points: 
  • EQT Infrastructure to acquire a 60 percent stake in newly created company which will own and operate the Italian telecom provider Wind Tre's mobile and fixed network.
  • Wind Tre's current owner, CK Hutchison, will remain invested alongside EQT Infrastructure and own a 40 percent stake in the Company.
  • The Italian mobile network is in need for investments and expansion over the coming years to meet this increasing demand.
  • EQT Infrastructure will leverage its long track record of developing digital infrastructure companies to support the Company's strategy.

Fosun International's 2021 Annual Report Wins Gold Award at the 2022 International ARC Awards

Retrieved on: 
Friday, January 27, 2023
The Spring Festival, Club Med, Letter, Hospital, Airport authority, Gold Award, Face, Ali Baba, Mainland China, Future, Hang Seng Bank, Commercial bank, NWS Holdings, Gold, China Construction Bank, New Year, CK Hutchison Holdings, Weather, Citigroup, Tablet, Happiness, Pharmaceutical industry in China, Fruit, CLP Group, Investment, HKEX, Photography, Morgan Stanley, Goldman Sachs, New World Development, Spring Festival, International, Annual report, Government, Imperial Bank of China, Accumulation, COVID-19, ARC, The Company, Organization, Vaccination, Film industry, Pharmaceutical industry, Fosun International, China Telecom, Nomura, Silver, Health, Azvudine

The 2021 annual report of Fosun International Limited ("Fosun International" or the "Company", HKEX: 00656) won Gold Award in the "Traditional Annual Report" category of the 2022 International ARC Awards.

Key Points: 
  • The 2021 annual report of Fosun International Limited ("Fosun International" or the "Company", HKEX: 00656) won Gold Award in the "Traditional Annual Report" category of the 2022 International ARC Awards.
  • Hailed as the "Academy Awards of annual reports", the International ARC Awards is the world's most prestigious competition honoring excellence in annual reports.
  • In addition to Fosun International, CK Hutchison Holdings and NWS Holdings also won awards in the Traditional Annual Report - Diversified Business category of the 2022 International ARC Awards.
  • Hailed as the "Academy Awards of annual reports", the International ARC Awards is globally recognized for its openness and fairness, providing a platform for the highest standards in the annual report industry.

Pharus, Inc. Names Philip C. Huang as Company CEO, Becomes Newest Player in Cancer Liquid Biopsy Market

Retrieved on: 
Monday, October 3, 2022
Algorithm, Solution, VP, Cancer, Liquid biopsy, Mirna, Time, Physician, ASCO, Technology, Precision medicine, Industry, Stanford University, Chemical engineering, MBA, CK Life Sciences, Roche, CK Hutchison Holdings, MicroRNA, CA, Roche Diagnostics, INSEAD, Philip, Leadership, Patient, MIT, Biomarker, Diagnosis, American Society of Clinical Oncology, Machine learning, Society, EKF Diagnostics, Data analysis, Medical imaging

LOS ANGELES, Oct. 3, 2022 /PRNewswire/ -- Pharus, Inc. ("PharusDx"), a new diagnostics company spun out from Hsinchu, Taiwan-based Quark Biosciences, has named Philip Huang as its Chief Executive Officer. PharusDx creates solutions for the early detection of cancer and is currently developing its OncoSweep™ Multi-Cancer Early Detection (MCED) liquid biopsy test as well as single-cancer liquid biopsy tests that evaluate microRNA (miRNA) within the body.

Key Points: 
  • PharusDx creates solutions for the early detection of cancer and is currently developing its OncoSweepMulti-Cancer Early Detection (MCED) liquid biopsy test as well as single-cancer liquid biopsy tests that evaluate microRNA (miRNA) within the body.
  • Before joining Roche, Mr. Huang was Vice President of Global Business Development for EKF Diagnostics, a UK point-of-care diagnostics company, where he led corporate strategy and solidified strategic partnerships.
  • PharusDx is entering the precision medicine market with the goal of changing cancer diagnosis, so that medical professionals can detect and treat cancer early, before it progresses to advanced disease.
  • Using OncoSweepMCED and single-cancer liquid biopsy tests, physicians can find circulating biomarkers for multiple forms of cancer by testing blood or other body fluid samples.

WeLab and Astra Complete the Acquisition of Bank Jasa Jakarta

Retrieved on: 
Monday, September 19, 2022
Allianz, Group, Health, BJJ, Acquisition, Growth, Financial Services Authority (Indonesia), Information technology, Partnership, Industry, Sequoia Capital, Mining, Subscription business model, Environment, Foundation, Small and medium enterprises in Mexico, CK Hutchison Holdings, Ownership, Technology, WeLab Bank, Astra, Solution, TOM Group, Science and technology in Asia, Financial assistance (share purchase), SATU, CITIC Bank International, Ecosystem, World, Financial services, OJK, MSME-Champions, Education, WeLab, TFB, World Bank Group, International Finance Corporation, Cryptocurrency, Renewable energy

HONG KONG, Sept. 19, 2022 /PRNewswire/ -- WeLab, a leading pan-Asian fintech platform, today announced the completion of the acquisition of an Indonesian commercial bank, PT Bank Jasa Jakarta (BJJ), together with PT Astra International Tbk (Astra), one of Indonesia's largest public companies. The completion is marked by the issuance of acquisition approval by the Financial Services Authority (OJK). For this transaction, a WeLab-led consortium, Welab Sky Limited (WeLab Sky), participated in the acquisition together with Astra's subsidiary PT Sedaya Multi Investama (Astra Financial). The WeLab-led consortium has drawn wide-spread support from existing and new investors, including Allianz X, Boyu Capital, Horizons Ventures, SCBX Group[1] and TFB (Taipei Fubon Bank) Capital.

Key Points: 
  • For this transaction, a WeLab-led consortium, Welab Sky Limited (WeLab Sky), participated in the acquisition together with Astra's subsidiary PT Sedaya Multi Investama (Astra Financial).
  • With the acquisition completed today, WeLab and Astra each holds 49.56% of BJJ shares, becoming the majority shareholders and joint controllers of the bank.
  • This is WeLab's second strategic partnership initiative with Astra since the formation of a fintech lending joint venture, PT Astra WeLab Digital Arta (AWDA), in 2018.
  • WeLab operates in three markets under multiple brands, including WeLend, and WeLab Bank in Hong Kong, various business lines in Mainland China, Maucash and a digital bank in Indonesia.

WeLab and Astra Complete the Acquisition of Bank Jasa Jakarta

Retrieved on: 
Monday, September 19, 2022
Allianz, Group, Health, BJJ, Acquisition, Growth, Financial Services Authority (Indonesia), Information technology, Partnership, Industry, Sequoia Capital, Mining, Subscription business model, Environment, Foundation, Small and medium enterprises in Mexico, CK Hutchison Holdings, Ownership, Technology, WeLab Bank, Astra, Solution, TOM Group, Science and technology in Asia, Financial assistance (share purchase), SATU, CITIC Bank International, Ecosystem, World, Financial services, OJK, MSME-Champions, Education, WeLab, TFB, World Bank Group, International Finance Corporation, Cryptocurrency, Renewable energy

HONG KONG, Sept. 19, 2022 /PRNewswire/ -- WeLab, a leading pan-Asian fintech platform, today announced the completion of the acquisition of an Indonesian commercial bank, PT Bank Jasa Jakarta (BJJ), together with PT Astra International Tbk (Astra), one of Indonesia's largest public companies. The completion is marked by the issuance of acquisition approval by the Financial Services Authority (OJK). For this transaction, a WeLab-led consortium, Welab Sky Limited (WeLab Sky), participated in the acquisition together with Astra's subsidiary PT Sedaya Multi Investama (Astra Financial). The WeLab-led consortium has drawn wide-spread support from existing and new investors, including Allianz X, Boyu Capital, Horizons Ventures, SCBX Group[1] and TFB (Taipei Fubon Bank) Capital.

Key Points: 
  • For this transaction, a WeLab-led consortium, Welab Sky Limited (WeLab Sky), participated in the acquisition together with Astra's subsidiary PT Sedaya Multi Investama (Astra Financial).
  • With the acquisition completed today, WeLab and Astra each holds 49.56% of BJJ shares, becoming the majority shareholders and joint controllers of the bank.
  • This is WeLab's second strategic partnership initiative with Astra since the formation of a fintech lending joint venture, PT Astra WeLab Digital Arta (AWDA), in 2018.
  • WeLab operates in three markets under multiple brands, including WeLend, and WeLab Bank in Hong Kong, various business lines in Mainland China, Maucash and a digital bank in Indonesia.

A.S. Watson’s Move to Invest USD400M in Supply Chain Transformation Has Strengthened its O+O Capabilities and Competitive Position During the Pandemic

Retrieved on: 
Thursday, August 25, 2022
COVID-19, Watsons, CEO, CK Hutchison Holdings, Safety, Digital technology, Convenience Retail Asia, Forecasting, WeChat, Solution, Mark (given name), A.S. Watson Group, Asia–Europe Foundation, Health, KPI, SAR, Year, KONG, Automation, Growth, Online shopping, Retail

The Groups flagship brand Watsons has also been voted Asias No.1 Pharmacy/Drugstore Brand by Campaign Asia for 13th consecutive year.

Key Points: 
  • The Groups flagship brand Watsons has also been voted Asias No.1 Pharmacy/Drugstore Brand by Campaign Asia for 13th consecutive year.
  • Whats behind the resilience of A.S. Watson in tackling the pandemic challenges in retail in the past two years while gaining in competitive position?
  • Besides investment in digital technology, retail systems and automation, big data, cloud technology and cyber security, the transformation in building O+O retail supply chain pays off during the pandemic.
  • And we are keen to build international partnerships with companies who have expert experience, products and solutions in supply chain.